Improving Colorectal Cancer Screening for Diverse Hispanics in Urban Primary Care

Colorectal Cancer Screening Clinical Trial

Official title:

Improving Colorectal Cancer (CRC) Screening for Diverse Hispanics in an Urban Primary Care Setting

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01569620
• Other study ID #: GCO 08-1159
• Status: Completed
• Phase: N/A
• First received: March 29, 2012
• Last updated: January 28, 2016
• Start date: April 2012
• Est. completion date: December 2015

Study information

• Verified date: January 2016
• Source: Icahn School of Medicine at Mount Sinai
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The proposed study seeks to investigate the impact of a culturally targeted print educational intervention on rates of colorectal cancer (CRC) screening via colonoscopy among Hispanics. If, as expected, the addition of culturally targeted materials to best clinical practices as compared to a) best clinical practices plus standard materials or b) best clinical practices alone leads to higher rates of CRC screening via colonoscopy then the culturally targeted print educational materials can be easily disseminated among this rapidly growing minority group who have low rates of CRC screening and whose disease is detected at later, less curable stages.

Description:

CRC is the 2nd leading cause of cancer death among Hispanic women and men. Hispanics are more likely to be diagnosed at more advanced disease stages compared to non-Hispanic whites and have a lower probability of survival. A key way to decrease mortality from CRC among Hispanics is to increase rates of CRC screening and thereby early detection of CRC. To address low screening rates, thereby increasing the prevention and early detection of CRC, the proposed research seeks to increase CRC colonoscopy screening among Hispanics. The primary aim is to investigate the impact of a culturally targeted print educational intervention designed to increase CRC screening via colonoscopy in a diverse group of Hispanics 50 years of age and older. Our long standing (since 1999) research platform has included significant community input through ongoing meetings with our Community Advisory Board (CAB) soliciting their viewpoints and concerns. In addition, we consult with key community members on an ongoing basis for additional input. A Randomized Clinical Trial (RCT) will be conducted with 400 Hispanics within the context of the best clinical practices currently provided at Mount Sinai. There are three study arms: 1) best clinical practices plus culturally relevant print materials, 2) best clinical practices plus standard print materials and 3) best clinical practices alone. These three arms will allow the investigation of the addition of print materials and the comparison of culturally relevant to standard print materials to assess the differential impact of each print format. This comparison controls for the possible benefit of adding standard print materials to best clinical practices and allows for investigation of the additional benefit of culturally targeted relevant materials over and above that of standard materials. Further, by including feedback from the community, we will be able to clearly understand the benefits of, and be able to disseminate culturally targeted materials among this rapidly growing minority group. If, as hypothesized, the addition of the culturally targeted print materials leads to higher rates of colonoscopy, they can then be easily disseminated among health care settings treating Hispanics.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 386
• Est. completion date: December 2015
• Est. primary completion date: December 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 50 Years to 85 Years

Eligibility

Inclusion Criteria:

• Self-identified Hispanic

• Between the ages of 50 and 85

• Able to provide informed consent in either English or Spanish

• No participation in study Focus Groups by a family member or oneself

• Referred for a screening colonoscopy by a primary care physician at Mount Sinai

• At average risk for developing colorectal cancer

• Have no colonoscopy procedure within the last 5 years

• Have telephone service

Exclusion Criteria:

• Personal history of CRC

• Personal history of any chronic GI disorder (irritable bowel syndrome, colitis) and

• Family history of CRC (first degree relative of CRC)

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

• Colorectal Cancer Screening
• Colorectal Neoplasms

Intervention

Behavioral:
• Best clinical practices plus culturally targeted print materials
This intervention arm includes best clinical practices (or usual care at MSSM) and the culturally relevant print materials developed for this study.
• Best clinical practices plus standard print materials
This intervention arm includes best clinical practices (or usual care at MSSM) and the standard CRC screening print materials developed by the Centers for Disease Control (CDC).
• Best clinical practices alone
This intervention arm includes best clinical practices (or standard/usual care at MSSM) and no additional print materials.

Locations

Country	Name	City	State
United States	Icahn School of Medicine at Mount Sinai	New York	New York

Sponsors (2)

Lead Sponsor	Collaborator
Icahn School of Medicine at Mount Sinai	Memorial Sloan Kettering Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change from baseline of colonoscopy at 3 months, 6 months, and 12 months.	Comparison of physician recommended colonoscopy (post intervention) obtained at approximately 3 months and 6 months (via self report) and at 12 months (as per chart review), to that of colonoscopy obtained at baseline.	Baseline, at 3 months, at 6 months, and at 12 months	No